Free Trial
ASX:COH

Cochlear (COH) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
201,277 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
1.21%
Price Target
N/A
COH stock logo

About Cochlear Stock (ASX:COH)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

COH Stock News Headlines

Cochlear Limited (COH.AX)
Bill Clinton Backing Biden Replacement???
Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.
Cochlear Limited (CHEOF) Gets a Sell from Morgan Stanley
Bill Clinton Backing Biden Replacement???
Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.
Here’s Why Cochlear (COH) Shares Fell Despite Robust Profits
Here’s Why Cochlear (COH) Shares Rose Today
Cochlear Ltd (OC5.SG)
Curro Holdings Ltd COH
Cochlear Ltd COH
See More Headlines
Receive COH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/19/2019
Ex-Dividend for 4/14 Dividend
3/20/2024
Dividend Payable
4/14/2024
Today
6/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
4,800
Year Founded
N/A

Profitability

Net Income
$350.40 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.15 billion
Book Value
A$27.17 per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
0.46
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Diggory William Howitt BE (Hons) (Age 57)
    MBA, CEO, MD, President & Executive Director
    Comp: $4.78M
  • Mr. Stuart Sayers
    Chief Financial Officer
  • Mr. Jan Janssen MSc Elec Eng (Age 59)
    Chief Technology Officer
    Comp: $2.04M
  • Ms. Karen O'Driscoll
    Chief Information Officer
  • Ms. Kristina Devon
    Vice President of Investor Relations
  • Rob McGrory
    Group General Counsel
  • Ms. Jennifer Stevenson
    VP of Corporate Communications & Brand
  • Mr. Dean Phizacklea
    Senior Vice President of Global Strategic Marketing
  • Ms. Jennifer Hornery
    Senior Vice President of Global People & Culture
  • Mr. Greg Bodkin BE (Hons)
    MComm (UNSW), Senior Vice President of Global Supply Chain

COH Stock Analysis - Frequently Asked Questions

How were Cochlear's earnings last quarter?

Cochlear Limited (ASX:COH) posted its earnings results on Tuesday, February, 19th. The company reported $2.15 EPS for the quarter, missing the consensus estimate of $2.19 by $0.04. Cochlear had a net margin of 16.30% and a trailing twelve-month return on equity of 20.04%.

How often does Cochlear pay dividends? What is the dividend yield for Cochlear?

Cochlear declared a Interim dividend on Monday, March 18th. Stockholders of record on Sunday, April 14th will be given a dividend of 2.00 per share on Sunday, April 14th. This represents a yield of 0.6%. The ex-dividend date of this dividend is Wednesday, March 20th. This is a positive change from the stock's previous Interim dividend of A$1.55.
Read our dividend analysis for COH
.

Is Cochlear a good dividend stock?

Cochlear (ASX:COH) pays an annual dividend of A$4.00 per share and currently has a dividend yield of 1.21%. The dividend payout ratio is 75.19%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for COH.

What other stocks do shareholders of Cochlear own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cochlear investors own include iShares Core S&P 500 ETF (IVV), CSL (CSL), ResMed (RMD), Rio Tinto Group (RIO), Altium (ALU), Abbott Laboratories (ABT), Afterpay (APT), Appen (APX), Cross Timbers Royalty Trust (CRT) and Janus Henderson Group (HGG).

This page (ASX:COH) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners